SELB

Selecta Biosciences, Inc NASDAQ Global Market
$2.58
Open: $2.54 High: $2.65 Low: $2.25 Close: $2.385
Range: 2022-08-08 - 2022-08-09
Volume:1,101,320
Market: Extended-hours
SELB
Selecta Biosciences, Inc 65 GROVE STREET https://www.selectabio.com
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.
  • CEO: Werner Cautreels
  • Employees: 58
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
SELB News
Latest news about the SELB